Bone Metastasis Clinical Trial
Official title:
Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma
The purpose is to evaluate if sodium fluoride PET in patients having already undergone a
choline PET negative for bone extension (non-metastatic status) modifies the status of
patients concerning the existence or not of bone metastases.
Secondary purposes are:
- To evaluate if detection of bone metastasis by sodium fluoride PET, not detected by
choline PET, leads to change of treatment
- To evaluate inter-technique concordance (choline vs sodium fluoride PET) of results
(metastatic status and number of lesions)
- To evaluate the inter-judge concordance of interpretation of sodium fluoride PET
- To study the discordance of metastatic status of 2 techniques.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01833806 -
A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
|
N/A | |
| Terminated |
NCT01586273 -
Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound for Pain Palliation of Bone Metastases
|
N/A | |
| Completed |
NCT02609828 -
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
|
Phase 3 | |
| Completed |
NCT04592887 -
Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|
N/A | |
| Recruiting |
NCT02231476 -
Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients
|
Phase 2 | |
| Recruiting |
NCT02426697 -
Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy
|
Phase 3 | |
| Completed |
NCT00334139 -
Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer
|
Phase 4 | |
| Completed |
NCT01784393 -
Chemoradiation for Bone Metastasis
|
Phase 2 | |
| Terminated |
NCT02999152 -
Validation of Radio-induced Damage Biomarkers
|
N/A | |
| Not yet recruiting |
NCT02480634 -
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
|
Phase 4 | |
| Completed |
NCT02784652 -
Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors
|
Phase 2 | |
| Completed |
NCT02673060 -
A Trial of MBC-11 in Patients With CIBD
|
Phase 1 | |
| Completed |
NCT02774213 -
A Study to Collect Data About Analgesia in Patients With Bone Metastasis
|
||
| Completed |
NCT02876731 -
Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)
|
N/A | |
| Recruiting |
NCT02705157 -
The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones
|
N/A | |
| Completed |
NCT01309048 -
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases
|
Phase 1/Phase 2 | |
| Completed |
NCT01062503 -
Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC
|
N/A | |
| Completed |
NCT00610272 -
Optimization of Radiotherapy in Treatment of Painful Bone Metastasis
|
Phase 3 | |
| Completed |
NCT01998607 -
Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw
|
N/A | |
| Completed |
NCT02293642 -
Bone Pain Score Validation Initiative
|